The board of directors of Viva Biotech Holdings announces the following changes of directors of the Company: Ms. SUN Yanyan ("Ms. SUN") has tendered her resignation from the office of a non-executive Director on November 14, 2022 with immediate effect. Ms. SUN resigned from her position in order to devote more time to pursue her other business engagements and has confirmed that she has no disagreement with the Board and there is no matter relating to her resignation that needs to be brought to the attention of the shareholders of the Company (the "Shareholder(s)") and The Stock Exchange of Hong Kong Limited (the "Stock Exchange"). The Board is delighted to announce that following Ms. SUN's resignation, the Board appointed Mr. WU Yuting ("Mr. WU") as a non-executive Director with effect from November 14, 2022. Mr. WU, aged 51, was previously an investment director and partner of Fenghe Fund Management Pte. Ltd. since May 2010. He was a general manager at Shanghai Zhifang Electronic Technology Co.,
Ltd. from July 1997 to January 2006. He was also an engineer at Shanghai Changjiang Computer System Integration Company from September 1994 to July 1997. Mr. WU obtained his bachelor's degree in computer and application from the Shanghai Jiao Tong University in July 1994, and he further obtained his international master's degree in business administration from the Schulich School of Business of York University in June 2008. In addition, Mr. WU is the brother of Mr. John WU Jiong, a substantial Shareholder of the Company who is taken to be interested in Shares held by Fenghe Harvest Ltd, Wu and Sons Limited and Fenghe Canary
Limited, each being a corporation controlled by him.